Prerequisites to implementing a pharmacogenomics program in a large health-care system
K D Levy, B S Decker, J S Carpenter, D A Flockhart, P R Dexter, Z Desta, T C Skaar, K D Levy, B S Decker, J S Carpenter, D A Flockhart, P R Dexter, Z Desta, T C Skaar
Abstract
Pharmacogenomics (PGx) technology is advancing rapidly; however, clinical adoption is lagging. The Indiana Institute of Personalized Medicine (IIPM) places a strong focus on translating PGx research into clinical practice. We describe what have been found to be the key requirements that must be delivered in order to ensure a successful and enduring PGx implementation within a large health-care system.
Conflict of interest statement
Conflicts of Interest
All authors have reported no conflicts of interest.
Figures
Alignment required within Clinical and Administrative groups in order to facilitate PGx Implementation that is effective and enduring
Is an example of how the Eskenazi EMR PGx Alert may appear when fully implemented
Source: PubMed